Met’s Elamite raptor helmet pairs “battle” imagery with gold-plated gods
A 3,500-year-old bronze masterpiece from southwestern Iran suggests elite status, symbolism, and battlefield warding.

A bronze Elamite helmet in the Metropolitan Museum of Art, dated circa 1500 to 1100 B.C., features a swooping raptor above three gold-plated deities. For decision-makers, it is a reminder that artifacts, like institutions, blend function with narrative power when power and conflict converge.
There is a specific kind of object that instantly changes the way you picture an ancient world: one that is both practical and theatrical. This Elamite bronze helmet, in the collection of the Metropolitan Museum of Art and dated circa 1500 to 1100 B.C., is built for exactly that kind of dual purpose. Its dome-shaped bronze body measures roughly 8.5 inches (21.6 centimeters) in diameter, with a thin cutaway on the front where it would have fit over the wearer’s eyebrows, plus a small projection that would have extended down to cover the nose. But the real headline is the decoration. A large bird of prey (a raptor) is positioned vertically over three gold-plated divine figures, turning head protection into a rolling piece of battlefield theater.
This story's Key Insights and Take-aways are locked.
Create a free account to unlock Executive Actions for one credit.
Register to UnlockAlways free for Executives Club members. Join the Club
More in Science
2026 Nikon Small World Winners Reveal the Hidden Machinery of Everyday Life
A mycologist's frozen Edinburgh garden became the backdrop for vivid views inside cells, a reminder of what advanced imaging now makes visible to researchers and the industries built on biology.
Study: 1 in 4 depression cases may be a body-clock problem, not a chemical one
A 10,000-person study finds standard antidepressants often fail these patients, but melatonin and morning sunlight may hit the real root cause.
Start-Up Says A.I. Designed a Virus to Attack One Patient's Superbug
If the claim holds up, personalized phage therapy could become a new frontline weapon against antibiotic resistance - but proof is far from final.


